Swiss food conglomerate Nestle is reportedly expanding its skincare portfolio after acquiring various injectable treatment patents in a $1.4 billion deal.
Reports say Nestle acquired the rights for various wrinkle treatments from Valeant Pharmaceuticals.
While the deal allows Nestle to own the rights to treatments acquired when it fully took over its …read more
Source: Global Competition Law Blogs